Flexible Brainstem Electrodes Preserved Frequency Maps for 136 Days in Rats
Health

Flexible Brainstem Electrodes Preserved Frequency Maps for 136 Days in Rats

An ultra-flexible penetrating array stimulated rat auditory pathways with frequency-selective patterns that remained broadly stable for more than 136 days. The work measured neural activity in normal-hearing animals, not restored hearing, speech perception or human safety.

NewTqnia Health Desk Updated 3 min read
Flexible Brainstem Electrodes Preserved Frequency Maps for 136 Days in Rats

Quick summary

  • An ultra-flexible penetrating electrode array mapped rat auditory responses from 0.5 to 32 kHz.
  • Stimulating the cochlear nucleus produced downstream frequency maps resembling responses to sound.
  • Recording and stimulation measures remained broadly stable for more than 136 days, with minimal gliosis reported.
  • The study used normal-hearing rats and did not test restored hearing, speech understanding or human safety.

Researchers have developed a penetrating auditory-brainstem electrode that produced frequency-selective neural activity and remained functional for more than four months in rats. The device, called uFINE, is intended as a possible route toward more precise auditory brainstem implants for people whose damaged or absent cochlear nerves make cochlear implants unsuitable.

The experiment demonstrated durable, ordered neural stimulation in normal-hearing rats. It did not demonstrate that an implanted animal or person could hear through the device.

Why current brainstem implants struggle

A cochlear implant stimulates the auditory nerve. An auditory brainstem implant instead targets the cochlear nucleus, the first brainstem relay for sound, when that nerve cannot carry a signal. Existing clinical devices generally place an electrode array on the surface of the brainstem.

Surface arrays have limited access to deeper neurons and can spread current across neighbouring regions. Outcomes therefore range from basic sound awareness to modest hearing benefit, while useful speech understanding remains inconsistent.

A flexible array that penetrates the target

uFINE uses a high-density, ultra-flexible array that enters the cochlear nucleus rather than resting only on its surface. The researchers recorded frequency tuning across 0.5 to 32 kHz in both the cochlear nucleus and the inferior colliculus, a downstream auditory centre.

When individual cochlear-nucleus sites were electrically stimulated, the response peaks in the inferior colliculus broadly followed the tonotopic map produced by sound. Tonotopy is the nervous system's spatial ordering of frequencies, with different locations responding best to different pitches.

Four months of neural-interface stability

The recordings and stimulation responses remained broadly stable for more than 136 days. The study reports no significant population-level drift in threshold, dynamic range or activation width, alongside minimal glial scarring around the implant. The array also endured extended electrochemical testing before implantation.

Electrical activation was not identical to natural hearing. Some response patterns were broader and had a narrower dynamic range than tone-evoked activity. Best-response locations also shifted in some animals without a consistent direction.

The pathway could be trained

In another experiment, daily sequential stimulation of the cochlear nucleus and inferior colliculus shifted the downstream response peak toward the targeted site. The result is consistent with use-dependent plasticity, suggesting repeated patterns can alter how the auditory pathway responds.

That plasticity is an electrophysiological finding, not proof of improved perception. NewTqnia previously covered a different implanted interface in one participant with ALS who controlled smart devices using silently mimed commands, where behavioural performance could be measured directly.

Reality check

The animals had normal hearing, and the study measured neural responses rather than restored hearing or behaviour. A penetrating brainstem implant must also address surgical targeting, tissue injury and long-term safety in larger brains. Several authors are inventors on a related Chinese patent, and one is a co-founder and shareholder of a company that assisted with electrode assembly.

What comes next

The technology needs testing in deaf animal models and non-human primates, followed by behavioural experiments that ask whether different stimulation sites create distinguishable auditory percepts. Human trials would require evidence that the improvement in frequency selectivity outweighs the additional risks of penetrating the brainstem.

Verified topics and entities

Sources and citations3 sources

Published by

N

NewTqnia Health Desk

An institutional editorial team within NewTqnia

A new version of NewTqnia is ready.